Reading note / Study limits
What did the study compare?
A reported change can be interesting without showing that the treatment caused it. The study’s design is part of the answer.
Start with the comparison
A comparison group is the people who get different care in a study. For example, one group might get usual care and Semax, while the other gets usual care without Semax. Researchers check whether the two groups improve differently.
Random assignment means using chance to decide who gets which treatment. Blinding means keeping patients or the people judging their progress from knowing which treatment they got.
Two Russian stroke studies, from 1997 and 2018, reported better recovery in people who got Semax alongside their usual care. Their short summaries did not say whether people were put into groups by chance or kept from knowing which treatment they got. Study summary: stroke study
Those reports cannot establish that Semax caused the gains.
Does this dismiss the work?
No. The studies reported that people improved. They leave open whether Semax was the reason.
What animal studies can tell you
Semax had effects in rats or mice, but how it produced those effects was poorly understood, according to the FDA review checked September 30, 2026. FDA’s Semax review
That work does not establish the same effects in people.
How does that help me read an offer?
Look for the word “people” in the explanation. Ask whether a claim comes from a human study or from work in an animal or a lab.
Read the conclusion with its limits
The FDA found too little evidence that Semax works for reduced blood flow to the brain, migraine or severe stabbing facial nerve pain. That finding is from its July 2026 review. FDA’s Semax review
Ask which finding relates to your concern. If the answer is about a different condition, ask how the doctor made that connection.